1
EXHIBIT 11.1
COULTER PHARMACEUTICAL, INC.
STATEMENT OF COMPUTATION OF NET LOSS PER SHARE
Year Ended Six Months Ended
December 31, June 30,
------------------------------- -------------------------------
1995 1996 1996 1997
------------ ------------- ------------- -------------
Historical primary EPS
Shares used in calculation of net
loss per share:
Weighted average common
stock outstanding: 257 107,780 2,059 8,724,623
Shares related to Staff Accounting
Bulletins Nos. 55, 64 and 83
Common stock: 401,788 301,341 401,788 --
Stock options: 559,600 419,700 559,600 --
Warrants: 173,067 129,800 173,067 --
Preferred stock; if converted 3,321,514 2,491,136 3,321,514 --
----------- ------------ ----------- -----------
4,456,226 3,449,757 4,458,027 8,724,623
----------- ------------ ----------- -----------
Net (loss) $(2,992,557) $(15,338,279) $(5,310,797) $(8,800,412)
----------- ------------ ----------- -----------
Net (loss) per share $(0.67) $(4.45) $(1.19) $(1.01)
=========== ============ =========== ===========
Proforma:
Shares used in calculation of net
loss per share:
Weighted average common
stock outstanding: 257 107,780 2,059
Preferred Stock, if converted 2,341,665 4,108,154 3,277,775
Shares related to Staff Accounting
Bulletins Nos. 55, 64 and 83
Common stock: 401,788 301,341 401,788
Stock options: 559,600 419,700 559,600
Warrants: 173,067 129,800 173,067
Preferred stock; if converted 3,321,514 2,491,136 3,321,514
----------- ------------ -----------
6,797,891 7,557,911 7,735,803
----------- ------------ -----------
Net (loss) $(2,992,557) $(15,338,279) $(5,310,797)
----------- ------------ -----------
Net (loss) per share $(0.44) $(2.03) $(0.69)
=========== ============ ===========